New guideline from the German Society for Anesthesiology that addresses the intraoperative clinical application of haemodynamic monitoring in non-cardiac surgical patients. The Executive Board of the German Society for Anesthesiology recently adopted a new guideline that addresses the intraoperative clinical application of haemodynamic...
READ MOREA Free Ventilator Simulator in Your Pocket The Hamilton Medical VenTrainer App offers healthcare professionals the unique opportunity to transform their mobile devices or computers into powerful ventilator simulators by providing hands-on knowledge in a safe and controlled environment. 360° Interactive Animation...
READ MOREAbionic, an innovative medical diagnostics company specialising in rapid early detection technologies, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its IVD CAPSULE PSP test. Abionic, an emerging medical diagnostics company focused on rapid early detection technologies, received 510(k) clearance for...
READ MOREVasopressin timing, patient selection, optimal vasopressin use in septic shock, and potential mortality benefits in selected patient populations. Septic Shock Overview and Current Treatments Septic shock is a severe, life-threatening response to infection, characterised by systemic inflammation, tissue hypoperfusion, and persistent,...
READ MOREIn a webinar at the ESICM Congress, Dr Aretha and Dr Garcia-Alvarez spoke about cardiovascular management after surgery. More specifically, Dr Aretha spoke about the management of post-operative atrial fibrillation, and Dr Garcia-Alvarez spoke about the importance of early application of vasopressin in septic shock patients. Management...
READ MOREAbionic SA has appointed Patrick Pestalozzi as CEO. With three decades of global experience in management consulting and entrepreneurship, Patrick has been instrumental in creating and developing deep-tech ventures. His diverse healthcare background positions him to lead Abionic's next growth phase. ICU Management & Practice interviewed Patrick...
READ MOREAthina Nasoufidou Second Department of Cardiology Aristotle University of Thessaloniki Hippokration General Hospital Thessaloniki, Greece A systematic review investigating landiolol's efficacy in non-septic or post-operated SVT patients with concomitant left ventricular dysfunction. Managing Supraventricular Tachyarrhythmias...
READ MOREAn overview of landiolol, a potent and cardioselective beta-blocker offering a promising addition to the armamentarium for managing acute cardiac conditions for rapid and effective rate control with minimal adverse effects. Cardiac emergencies present complex challenges in emergency medical settings, requiring prompt and effective management...
READ MOREAn overview of vasopressor management, current evidence on its use, when to initiate vasopressor therapy for best possible patient outcome and a discussion regarding the use of landiolol in septic patients with persistent tachycardia. Optimising Vasopressin Initiation in Septic Shock Patients with septic shock, and especially...
READ MOREVasopressin and landiolol are critical therapies for ensuring the vascular and cardiac systems are as close to optimal conditions as possible during septic shock. Better cardiovascular management in septic shock can help improve septic shock management. Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response...
READ MOREXenios sponsored a lunch symposium at the 16th European Conference on Paediatric and Neonatal Ventilation (EPNV) in Montreux (CH) in May 2023. Matteo Di Nardo (Italy) introduced the audience to extracorporeal membrane oxygenation (ECMO) in neonates. Florian Kipfmüller (Germany) presented current knowledge and his experience with ECMO in neonates...
READ MORE